Published in N Engl J Med on June 09, 2011
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med (2011) 11.11
Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87
Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes (2003) 2.16
Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes (2007) 2.08
Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes (2003) 1.92
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol (2008) 1.88
An increase in the cell component of the cortical interstitium antedates interstitial fibrosis in type 1 diabetic patients. Kidney Int (2002) 1.80
The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes (2002) 1.79
Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol (2013) 1.77
Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes (2002) 1.70
The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes (2005) 1.67
Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol (2005) 1.63
Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int (2002) 1.61
Histopathology of diabetic nephropathy. Semin Nephrol (2007) 1.60
The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study. Diabetes (2005) 1.40
Podocyte structural parameters do not predict progression to diabetic nephropathy in normoalbuminuric type 1 diabetic patients. Am J Nephrol (2015) 1.39
Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes (2005) 1.34
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient. Diab Vasc Dis Res (2008) 1.27
Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease. Kidney Int (2010) 1.25
Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry. Clin J Am Soc Nephrol (2010) 1.24
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation. Nephrol Dial Transplant (2011) 1.23
Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy. J Am Soc Nephrol (2003) 1.21
Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol (2014) 1.20
Proposed pathogenesis of idiopathic loin pain-hematuria syndrome. Am J Kidney Dis (2006) 1.18
Diabetes and nephropathy. Curr Opin Nephrol Hypertens (2003) 1.16
Glomerulotubular junction abnormalities are associated with proteinuria in type 1 diabetes. J Am Soc Nephrol (2006) 1.16
Enhancing the predictive value of urinary albumin for diabetic nephropathy. J Am Soc Nephrol (2006) 1.14
Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. Circulation (2013) 1.13
Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study. Curr Diab Rep (2013) 1.09
GFR-estimating models in kidney transplant recipients on a steroid-free regimen. Nephrol Dial Transplant (2010) 1.04
Comparison of methods for counting cells in the mouse glomerulus. Nephron Exp Nephrol (2006) 1.03
Diabetic nephropathy: diabetic nephropathy-challenges in pathologic classification. Nat Rev Nephrol (2010) 1.01
Renal lesions predict progression of diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol (2013) 1.01
Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes. Eur J Endocrinol (2004) 1.00
Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes. Diabetes (2002) 1.00
Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes (2003) 0.99
Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Pediatr Endocrinol Rev (2008) 0.97
Fabry disease: dose matters. J Am Soc Nephrol (2014) 0.97
Albumin excretion rate in normal adolescents: relation to insulin resistance and cardiovascular risk factors and comparisons to type 1 diabetes mellitus patients. Clin J Am Soc Nephrol (2008) 0.96
The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study. Ophthalmology (2006) 0.96
Arterial stiffness and cognition in elderly persons with impaired glucose tolerance and microalbuminuria. J Gerontol A Biol Sci Med Sci (2008) 0.95
Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabetes Care (2013) 0.95
Renal complications of Fabry disease in children. Pediatr Nephrol (2012) 0.93
Diabetic nephropathy is associated with gene expression levels of oxidative phosphorylation and related pathways. Diabetes (2006) 0.92
Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products. Diabetes Care (2013) 0.90
Insulin resistance and the cluster of abnormalities related to the metabolic syndrome are associated with reduced glomerular filtration rate in patients with type 2 diabetes. Diabetes Care (2006) 0.90
Gene expression differences in skin fibroblasts in identical twins discordant for type 1 diabetes. Diabetes (2012) 0.89
Progression of diabetic nephropathy in type 1 diabetic patients. Diabetes Res Clin Pract (2008) 0.89
Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. J Am Soc Nephrol (2002) 0.87
Assessment of renal pathology and dysfunction in children with Fabry disease. Clin J Am Soc Nephrol (2010) 0.84
The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes. Diabetes (2002) 0.84
PC-1 amino acid variant Q121 is associated with a lower glomerular filtration rate in type 2 diabetic patients with abnormal albumin excretion rates. Diabetes Care (2003) 0.83
Bariatric surgery improves atherogenic LDL profile by triglyceride reduction. Obes Surg (2008) 0.83
Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complications (2012) 0.83
Having one kidney does not accelerate the rate of development of diabetic nephropathy lesions in type 1 diabetic patients. Diabetes (2008) 0.83
Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes. Am J Kidney Dis (2008) 0.83
Estimating mean glomerular volume using two arbitrary parallel sections. J Am Soc Nephrol (2002) 0.83
Temporal profile of diabetic nephropathy pathologic changes. Curr Diab Rep (2013) 0.83
Reversal of diabetic nephropathy: lessons from pancreas transplantation. J Nephrol (2012) 0.81
Benefits of Renin-Angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control. Diabetes Care (2011) 0.81
Morphologic features of declining renal function in type 1 diabetes. Semin Nephrol (2012) 0.81
Glomerular structure in the normal human kidney: differences between living and cadaver donors. J Am Soc Nephrol (2003) 0.81
Effects of pancreas transplantation on the prevention and reversal of diabetic nephropathy. Contrib Nephrol (2011) 0.80
Urinary albumin as an indicator of diabetic nephropathy lesions in Japanese type 2 diabetic patients. Nephron (2002) 0.80
Cellular basis of diabetic nephropathy: IV. Antioxidant enzyme mRNA expression levels in skin fibroblasts of type 1 diabetic sibling pairs. Nephrol Dial Transplant (2006) 0.80
Glomerular structural factors in progression of congenital nephrotic syndrome. Pediatr Nephrol (2003) 0.80
Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparation. Amino Acids (2013) 0.79
Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipients. Clin J Am Soc Nephrol (2010) 0.79
Cat-scratch disease relapse in a kidney transplant recipient. Pediatr Transplant (2007) 0.79
Relationship of blood pressure to retinal vessel diameter in type 1 diabetes mellitus. Arch Ophthalmol (2010) 0.79
Enalapril accelerates remodeling of the renal interstitium after release of unilateral ureteral obstruction in rats. J Nephrol (2003) 0.78
Quantitating glomerular endothelial fenestration: an unbiased stereological approach. Am J Nephrol (2011) 0.78
The kidney in type 2 diabetes: focus on renal structure. Endocrinol Nutr (2009) 0.78
Comparing the automated versus manual method of needle biopsy for renal histology artefacts. Nephrol Dial Transplant (2008) 0.78
Pancreas transplantation and reversal of diabetic nephropathy lesions. Med Clin North Am (2012) 0.77
Effect of angiotensin II on glomerular structure in streptozotocin-induced diabetic rats. Am J Nephrol (2004) 0.77
Angiotensin II receptor blocker pretreatment of rats undergoing sudden renal ablation. Nephrol Dial Transplant (2011) 0.77
Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes. J Hypertens (2016) 0.76
Cellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetes. J Diabetes Complications (2009) 0.76
Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes. Eur J Endocrinol (2002) 0.76
Angiotensin II receptor blockade blocker pre-treatment largely prevents injury from gradual renal ablation in rats. J Renin Angiotensin Aldosterone Syst (2007) 0.76
Adherence and renal biopsy feasibility in the Renin Angiotensin-System Study (RASS) primary prevention diabetes trial. Diabetes Res Clin Pract (2013) 0.75
Predilection of segmental glomerulosclerosis lesions for the glomerulotubular junction area in type 1 diabetic patients: a novel mapping method. PLoS One (2013) 0.75
Albuminuria according to status of autoimmunity and insulin sensitivity among youth with type 1 and type 2 diabetes. Diabetes Care (2013) 0.75
Glomerulopathy in spontaneously obese rhesus monkeys with type 2 diabetes: a stereological study. Diabetes Metab Res Rev (2011) 0.75
Preventing microalbuminuria in type 2 diabetes. N Engl J Med (2005) 0.75
Microalbuminuria in patients with cystic fibrosis. Diabetes Care (2011) 0.75
Erratum. Nephrol Dial Transplant (2017) 0.75
Idiopathic intracranial hypertension immediately after kidney transplantation in a pediatric recipient. Pediatr Nephrol (2004) 0.75
Diagnostic pathways of the complex patients: rapid intensive observation in an Acute Medical Unit. Intern Emerg Med (2011) 0.75
Lactic acidosis and hypoglycemia with ALL relapse following engrafted bone marrow transplant. Pediatr Blood Cancer (2009) 0.75
A re-evaluation of the renal ablation model of progressive renal disease in rats. J Nephrol (2003) 0.75